We are live on ! Find out more
PC

Pier Capital Portfolio holdings

AUM $755M
1-Year Est. Return 94.38%
This Fund
S&P 500
This Quarter Est. Return
+8.16%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$997M
AUM Growth
-$57.5M
Cap. Flow
-$122M
Cap. Flow %
-12.22%
Top 10 Hldgs %
13.92%
Holding
125
New
8
Increased
27
Reduced
74
Closed
9

Top Sells

Rank Stock Value
1
MEI icon
Methode Electronics
MEI
+$12.7M
2
RDFN
Redfin
RDFN
+$12.7M
3
DIOD icon
Diodes
DIOD
+$12.3M
4
CCRD
CoreCard
CCRD
+$12M
5
QTWO icon
Q2 Holdings
QTWO
+$9.26M

Sector Composition

Rank Sector Weight
1 Technology 30.69%
2 Healthcare 22.32%
3 Industrials 14.98%
4 Consumer Discretionary 13.37%
5 Financials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POSH
76
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$8.18M 0.82%
+171,301
New +$7.35M
ADPT icon
77
Adaptive Biotechnologies
ADPT
$3.89B
$8.16M 0.82%
199,697
+42,736
+27% +$1.66M
OMCL icon
78
Omnicell
OMCL
$1.69B
$7.99M 0.8%
52,726
-33,103
-39% -$4.61M
PSNL icon
79
Personalis
PSNL
$1.54B
$7.86M 0.79%
310,616
+5,357
+2% +$123K
WK icon
80
Workiva
WK
$3.7B
$7.83M 0.79%
70,340
-10,027
-12% -$974K
OLLI icon
81
Ollie's Bargain Outlet
OLLI
$4.73B
$7.62M 0.76%
90,627
+18,891
+26% +$1.64M
SITE icon
82
SiteOne Landscape Supply
SITE
$4.22B
$7.34M 0.74%
43,355
-5,833
-12% -$1.02M
ALLO icon
83
Allogene Therapeutics
ALLO
$683M
$7.27M 0.73%
278,828
+5,182
+2% +$148K
AFIB
84
DELISTED
Acutus Medical Inc
AFIB
$7.25M 0.73%
427,049
-55,434
-11% -$811K
NARI
85
DELISTED
Inari Medical, Inc. Common Stock
NARI
$7.16M 0.72%
76,708
+25,802
+51% +$2.5M
ALEC icon
86
Alector
ALEC
$228M
$7.02M 0.7%
336,914
-168,489
-33% -$3.18M
MYOV
87
DELISTED
Myovant Sciences Ltd.
MYOV
$6.84M 0.69%
300,616
-254,163
-46% -$5.35M
VITL icon
88
Vital Farms
VITL
$495M
$6.73M 0.67%
336,967
+91,577
+37% +$2.03M
SDGR icon
89
Schrodinger
SDGR
$1.38B
$6.51M 0.65%
86,172
-11,943
-12% -$866K
BLFS icon
90
BioLife Solutions
BLFS
$1.72B
$6.46M 0.65%
145,145
-17,703
-11% -$624K
DV icon
91
DoubleVerify
DV
$2.04B
$6M 0.6%
+141,774
New +$5.05M
TNDM icon
92
Tandem Diabetes Care
TNDM
$1.63B
$6M 0.6%
61,613
-9,417
-13% -$840K
RVNC
93
DELISTED
Revance Therapeutics, Inc.
RVNC
$5.05M 0.51%
+170,316
New +$4.91M
RGEN icon
94
Repligen
RGEN
$9.45B
$5.04M 0.51%
25,232
-25,424
-50% -$4.93M
LGIH icon
95
LGI Homes
LGIH
$1.32B
$4.92M 0.49%
30,412
-25,921
-46% -$4.29M
PODD icon
96
Insulet
PODD
$10.1B
$1.41M 0.14%
5,126
+1,852
+57% +$503K
CRSP icon
97
CRISPR Therapeutics
CRSP
$5.22B
$1.03M 0.1%
+6,374
New +$775K
COUP
98
DELISTED
Coupa Software Incorporated
COUP
$942K 0.09%
3,594
+1,402
+64% +$347K
PINS icon
99
Pinterest
PINS
$13.2B
$846K 0.08%
10,718
-5,273
-33% -$368K
WIX icon
100
WIX.com
WIX
$3.35B
$804K 0.08%
2,771
-450
-14% -$126K

Similar funds

Pier Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Pier Capital held 125 positions worth $997M, down 5.5% from $1.05B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Pier Capital withdrew a net $122M in Q2 2021, closing 9 positions and reducing 74 holdings. Its most notable exit was Methode Electronics, an estimated $12.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Pier Capital opened a new position in Everbridge, Inc. Common Stock worth $13M.

  • Pier Capital's largest Q2 2021 buy was Everbridge, Inc. Common Stock: 95,651 shares worth $13M.
  • Pier Capital added most to Lindblad Expeditions in Q2 2021, an estimated $6.1M increase.
  • Pier Capital's biggest Q2 2021 reduction was Progyny, cutting an estimated $6.68M.
  • Pier Capital fully exited Methode Electronics in Q2 2021, selling an estimated $12.7M.
  • Pier Capital's ten largest holdings make up 14% of its $997M portfolio in Q2 2021.
  • Pier Capital opened 8 new positions and closed 9 in Q2 2021.
  • Pier Capital's portfolio value fell 5.5% quarter-over-quarter to $997M.

Based on Pier Capital's 13F filing for Q2 2021, filed 12 Aug 2021.